Portfolio Category: Current
June 6, 2020
Ventyx Biosciences
Developing selective inhibitors of TYK2 for autoimmune diseases.
Read MoreOctober 18, 2018
DUST Identity
Utilizes diamond crystals to enable secure identification of physical objects.
Read More